Published in Health Insurance Law Weekly, May 1st, 2005
This trend is creating an increased interest in routes of administration that are patient-friendly and cost-effective.
A significant number of new therapeutic compounds winding their way through development and clinical trials - particularly protein and peptide-based drugs - are being formulated for injection. To address these market forces, a growing...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Insurance Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.